We hope to welcome back visitors who knew the old site, and encourage many more people to visit and explore the resources now on offer.
The aim of the site is to put extracts from thyroid-related medical research online and to trace the development of diagnosis and treatment. Patients will find it useful for an in depth exploration of their conditions. Doctors and medical students will discover a wealth of information, much of it previously not available except from specialist libraries with restricted access. Medical historians will be saved long trips to libraries and can obtain articles dating back more than a century.
The website has been comprehensively redesigned to make it easy on the eye and simple to use. We have a powerful search facility that allows for easy retrieval of articles. We will send out a newsletter whenever we add new material. Put your email address in the box on the left of this page to join our mailing list.
There are 2769 articles online!
5 RECENTLY ADDED PUBLICATIONS
DATE ADDED: 22.11.2006
AUTHOR: Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH
PUBLICATION: J Sex Med. 2005 Nov;2(6):865-70.
DATE PUBLISHED: 20.11.2002
TITLE: Thyroid-stimulating hormone assessments in a Dutch cohort of 620 men with lifelong premature ejaculation without erectile dysfunction.
TEXT: INTRODUCTION: Apart from the involvement of central serotonergic neurotransmission on lifelong premature ejaculation, interference of thyroid function has been speculated. AIM: To study thyroid function in a large group of men with lifelong premature ejaculation (LPE). METHODS: Lifelong premature ejaculation was defined as an intravaginal ejaculation latency time (IELT) of less than 1 minute. Any consecutive man with LPE and no erectile dysfunction assessed by medical history and the Internation...
IMAGES: NO
DATE ADDED: 22.11.2006
AUTHOR: Hoekema A, Stel AL, Stegenga B, van der Hoeven JH, Wijkstra PJ, van Driel MF, de Bont LG
PUBLICATION: J Sex Med. 2006 Nov 1; [Epub ahead of print]
DATE PUBLISHED: 20.11.2001
TITLE: Sexual Function and Obstructive Sleep Apnea-Hypopnea: A Randomized Clinical Trial Evaluating the Effects of Oral-Appliance and Continuous Positive Airway Pressure Therapy.
TEXT: Introduction. The obstructive sleep apnea-hypopnea syndrome (OSAHS) is associated with sexual dysfunction. Although successful treatment with continuous positive airway pressure (CPAP) has been demonstrated to improve sexual function, the effects of oral-appliance therapy are unknown. Aim. The aims of this study were to determine to what extent untreated male OSAHS patients experience sexual dysfunctions compared with control subjects, and second, to evaluate the effects of oral-appliance and CP...
IMAGES: NO
DATE ADDED: 22.11.2006
AUTHOR: Muller A,, Mulhall JP
PUBLICATION: Curr Opin Urol. 2006 Nov;16(6):435-43.
DATE PUBLISHED: 20.11.2016
TITLE: Cardiovascular disease, metabolic syndrome and erectile dysfunction.
TEXT: PURPOSE OF REVIEW: Erectile dysfunction and cardiovascular disease share the same risk factors such as hypertension, diabetes, dyslipidemia, obesity, and smoking, all of which are implicated in causing endothelial dysfunction. In this review, an overview is given on the role of endothelium in the pathophysiology of erectile dysfunction, cardiovascular disease, and the metabolic syndrome as well as the links between them. RECENT FINDINGS: Current literature offers strong evidence that endothelial...
IMAGES: NO
DATE ADDED: 22.11.2006
AUTHOR: Rosen RC, Jackson G, Kostis JB
PUBLICATION: Curr Urol Rep. 2006 Nov;7(6):490-6. Review.
DATE PUBLISHED: 20.11.2007
TITLE: Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference.
TEXT: Erectile dysfunction (ED) has been linked increasingly to cardiovascular risk factors and comorbidities. Considering the potential risk associated with sexual activity, guidelines were developed (Princeton I) for assessment and management of patients with varying degrees of cardiac risk. These guidelines were recently updated (Princeton II) based on new data concerning the link between ED and cardiovascular disease and the availability of additional phosphodiesterase type 5 inhibitors (vardenafi...
IMAGES: NO
DATE ADDED: 22.11.2006
AUTHOR: Jan de Jong F, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ, Breteler MM
PUBLICATION: J Clin Endocrinol Metab. 2006 Nov 14; [Epub ahead of print]
DATE PUBLISHED: 20.11.2014
TITLE: The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.
TEXT: Context: Thyroid function has been related to Alzheimer disease (AD) and neuro-imaging markers thereof. Whether thyroid dysfunction contributes to or results from developing AD remains unclear. Variations in the deiodinase type 1 (DIO1) and type 2 (DIO2) genes that potentially alter thyroid hormone bioactivity may help elucidating the role of thyroid function in AD. Objective: We investigated the association of recently identified polymorphisms in the DIO1 (D1a-C/T, D1b-A/G) and DIO2 (D2-ORFa-Gl...
IMAGES: NO